This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

QTc and Metabolic Parameters

W. Victor R. Vieweg, MD

Published: May 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: My colleagues and I have been interested in QTc interval prolongation, torsade de pointes, and antipsychotic drugs for some time.1-9 The article by Mackin and Young10 in the November 2005 issue of the Journal has sufficient limitations both in its own right and as a model for a larger study to stimulate the following comments:

  • In the Introduction, Mackin and Young assert a need to examine "the relationship between QTc interval, antipsychotic use, and metabolic dysfunction."10(p1387)

‘ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Metabolic Disorder , Side Effects-Medication

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...